about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
31.99
1.05
(3.39%)
323.3K
XNAS Volume
XNAS 05 Sep, 2025 10:01 AM (EDT)
Board Meeting
The next board meeting for Cg Oncology Inc. is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..